Posts filed under ‘Rickettsias’

Update on Tick-Borne Rickettsioses around the World: a Geographic Approach

Clin. Microbiol. Rev. October 2013 26(4): 657-702

Philippe Parola, Christopher D. Paddock, Cristina Socolovschi, Marcelo B. Labruna, Oleg Mediannikov, Tahar Kernif, Mohammad Yazid Abdad, John Stenos, Idir Bitam, Pierre-Edouard Fournier, and Didier Raoult

Aix Marseille Université, Unité de Recherche en Maladies Infectieuses et Tropicales Emergentes (URMITE), UM63, CNRS 7278, IRD 198, Inserm 1095, WHO Collaborative Center for Rickettsioses and Other Arthropod-Borne Bacterial Diseases, Faculté de Médecine, Marseille, Francea

Centers for Disease Control and Prevention, Atlanta, Georgia, USAb

Departamento de Medicina Veterinária Preventiva e Saúde Animal, Faculdade de Medicina Veterinária e Zootecnia Universidade de São Paulo, Cidade Universitária, São Paulo, SP, Brazilc

Service d’Ecologie des Systèmes Vectoriels, Institut Pasteur d’Algérie, Algiers, Algeriad

Division of Veterinary and Biomedical Science, Murdoch University, Australian Rickettsial Reference Laboratory, Barwon Health, Geelong, Victoria, Australiae

University of Boumerdes, Boumerdes, Algeriaf

Tick-borne rickettsioses are caused by obligate intracellular bacteria belonging to the spotted fever group of the genus Rickettsia. These zoonoses are among the oldest known vector-borne diseases. However, in the past 25 years, the scope and importance of the recognized tick-associated rickettsial pathogens have increased dramatically, making this complex of diseases an ideal paradigm for the understanding of emerging and reemerging infections. Several species of tick-borne rickettsiae that were considered nonpathogenic for decades are now associated with human infections, and novel Rickettsia species of undetermined pathogenicity continue to be detected in or isolated from ticks around the world. This remarkable expansion of information has been driven largely by the use of molecular techniques that have facilitated the identification of novel and previously recognized rickettsiae in ticks. New approaches, such as swabbing of eschars to obtain material to be tested by PCR, have emerged in recent years and have played a role in describing emerging tick-borne rickettsioses. Here, we present the current knowledge on tick-borne rickettsiae and rickettsioses using a geographic approach toward the epidemiology of these diseases.

PDF

http://cmr.asm.org/content/26/4/657.full.pdf+html

 

ERRATUM

Page 672, column 1, line 33: “DQ34462” should read “DQ344620.”

 

Page 672, column 1, line 39: “EF68975.1” should read “EF689735.”

 

Page 672, column 2, line 10: “AY63102” should read “AY763102.”

 

http://cmr.asm.org/content/27/1/166.short

Advertisements

August 24, 2016 at 8:33 am

Fever of unknown origin in returning travellers.

Int Marit Health. 2015;66(2):77-83.

Korzeniewski K1, Gaweł B, Krankowska D, Wasilczuk K.

Author information

1Department of Epidemiology and Tropical Medicine in Gdynia, Military Institute of Medicine, Warsaw, Poland. kktropmed@wp.pl.

Abstract

The aim of the article is to discuss issues associated with the occurrence of febrile illnesses in leisure and business travellers, with a particular emphasis on fevers of unknown origin (FUO).

FUO, apart from diarrhoeas, respiratory tract infections and skin lesions, are one of the most common health problems in travellers to tropical and subtropical countries.

FUO are manifestations of various diseases, typically of infectious or invasive aetiology.

In one out of 3 cases, the cause of a fever in travellers returning from the hot climate zone is malaria, and therefore diagnostic tests should first aim at ruling out this specific disease entity.

Other illnesses with persistent fever include dengue, enteric fever, viral hepatitis A, bacterial diarrhoeas and rickettsioses.

Fever may also occur in travellers suffering from diseases of non-tropical origin, e.g. cosmopolitan respiratory tract or urinary tract infections, also, fever may coexist with other illnesses or injuries (skin rashes, bites, burns).

PDF (CLIC in DOWNLOAD)

http://czasopisma.viamedica.pl/imh/article/view/42436

September 27, 2015 at 4:36 pm

Rickettsial infection in Amblyomma cajennense ticks and capybaras (Hydrochoerus hydrochaeris) in a Brazilian spotted fever-endemic area.

Parasit Vectors. 2014 Jan 5;7:7.

Krawczak FS1, Nieri-Bastos FA, Nunes FP, Soares JF, Moraes-Filho J, Labruna MB.

Author information

1Department of Preventive Veterinary medicine and animal Health, Faculty of Veterinary Medicine, University of São Paulo, São Paulo, SP 05508-270, Brazil. felipekvet@gmail.com.

Abstract

BACKGROUND:

Brazilian spotted fever (BSF), caused by the bacterium Rickettsia rickettsii, is the deadliest spotted fever of the world. In most of the BSF-endemic areas, capybaras (Hydrochoerus hydrochaeris) are the principal host for the tick Amblyomma cajennense, which is the main vector of BSF.

METHODS:

In 2012, a BSF case was confirmed in a child that was bitten by ticks in a residential park area inhabited by A. cajennense-infested capybaras in Itú municipality, southeastern Brazil. Host questing A. cajennense adult ticks were collected in the residential park and brought alive to the laboratory, where they were macerated and intraperitoneally inoculated into guinea pigs. A tick-inoculated guinea pig that presented high fever was euthanized and its internal organs were macerated and inoculated into additional guinea pigs (guinea pig passage). Tissue samples from guinea pig passages were also used to inoculate Vero cells through the shell vial technique. Infected cells were used for molecular characterization of the rickettsial isolate through PCR and DNA sequencing of fragments of three rickettsial genes (gltA, ompA, and ompB). Blood serum samples were collected from 172 capybaras that inhabited the residential park. Sera were tested through the immunofluorescence assay using R. rickettsii antigen.

RESULTS:

A tick-inoculated guinea pig presented high fever accompanied by scrotal reactions (edema and marked redness). These signs were reproduced by consecutive guinea pig passages. Rickettsia was successfully isolated in Vero cells that were inoculated with brain homogenate derived from a 3rd passage-febrile guinea pig. Molecular characterization of this rickettsial isolate (designated as strain ITU) yielded DNA sequences that were all 100% identical to corresponding sequences of R. rickettsii in Genbank. A total of 83 (48.3%) out of 172 capybaras were seroreactive to R. rickettsii, with endpoint titers ranging from 64 to 8192.

CONCLUSIONS:

A viable isolate of R. rickettsii was obtained from the tick A. cajennense, comprising the first viable R. rickettsi isolate from this tick species during the last 60 years. Nearly half of the capybara population of the residential park was seroreactive to R. rickettsii, corroborating the findings that the local A. cajennense population was infected by R. rickettsii.

PDF

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892071/pdf/1756-3305-7-7.pdf

April 11, 2014 at 2:14 pm

Rickettsioses and the international traveler.

Clin Infect Dis 2004 Nov 15; 39(10) :1493-9.

Jensenius M, Fournier PE, Raoult D

Department of Internal Medicine, Aker University Hospital, Oslo, Norway. mogens.jensenius@ioks.uio.no

Abstract

The rickettsioses–zoonotic bacterial infections transmitted to humans by arthropods–were for many years considered to be oddities in travel medicine. During the previous 2 decades, however, reports of >450 travel-associated cases have been published worldwide, the vast majority being murine typhus caused by Rickettsia typhi, Mediterranean spotted fever caused by Rickettsia conorii, African tick bite fever caused by Rickettsia africae, and scrub typhus caused by Orientia tsutsugamushi. Most patients present with a benign febrile illness accompanied by headache, myalgia, and cutaneous eruptions, but severe complications and fatalities are occasionally seen. Current microbiological tests include culture, polymerase chain reaction, and serological analysis, of which only the latter method is widely available. Tetracyclines are the drugs of first choice and should be prescribed whenever a case of rickettsiosis is suspected. Preventive measures rely on minimizing the risk of arthropod bites when traveling in areas of endemicity.

PDF

http://cid.oxfordjournals.org/content/39/10/1493.full.pdf+html

July 12, 2013 at 3:07 pm

A patient from Argentina infected with Rickettsia massiliae.

Am J Trop Med Hyg. 2010 Apr;82(4):691-2.

García-García JC, Portillo A, Núñez MJ, Santibáñez S, Castro B, Oteo JA.

Source

Servicio de Medicina Interna, Hospital do Salnés, Villagarcía de Arosa, Pontevedra, Spain. juan.carlos.garcia.garcia@sergas.es

Abstract

The first confirmed case of Rickettsia massiliae infection in the New World (Buenos Aires, Argentina) is described. To date, only two cases of human infection had been reported in Europe. The patient, a woman, had a fever, a palpable purpuric rash on the upper and lower extremities, and a skin lesion (eschar) on the right leg compatible with tache noire. When interviewed, she reported having had contact with dog ticks. After treatment with doxycycline for 12 days, her symptoms resolved. Rickettsia massiliae infection was diagnosed by molecular-based detection of the microorganism in a biopsy specimen of the eschar.

PDF

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844561/pdf/tropmed-82-691.pdf

December 10, 2012 at 3:44 pm

Rickettsia parkeri in Argentina.

Emerg Infect Dis. 2008 Dec;14(12):1894-7.

Nava S, Elshenawy Y, Eremeeva ME, Sumner JW, Mastropaolo M, Paddock CD.

Source

Instituto Nacional de Tecnología Agropecuaria, Santa Fe, Argentina.

Abstract

Clinical reports of an eschar-associated rickettsiosis in the Paraná River Delta of Argentina prompted an evaluation of Amblyomma triste ticks in this region. When evaluated by PCR, 17 (7.6%) of 223 questing adult A. triste ticks, collected from 2 sites in the lower Paraná River Delta, contained DNA of Rickettsia parkeri.

PDF

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634642/pdf/08-0860_finalD.pdf

December 10, 2012 at 3:43 pm

Rickettsia parkeri Rickettsiosis, Argentina.

Emerg Infect Dis. 2011 Jul;17(7):1169-73.

Romer Y, Seijo AC, Crudo F, Nicholson WL, Varela-Stokes A, Lash RR, Paddock CD.

Source

Hospital F.J. Muniz, Buenos Aires, Argentina. yromer@hotmail.com

Abstract

Rickettsia parkeri, a recently identified cause of spotted fever rickettsiosis in the United States, has been found in Amblyomma triste ticks in several countries of South America, including Argentina, where it is believed to cause disease in humans. We describe the clinical and epidemiologic characteristics of 2 patients in Argentina with confirmed R. parkeri infection and 7 additional patients with suspected R. parkeri rickettsiosis identified at 1 hospital during 2004-2009. The frequency and character of clinical signs and symptoms among these 9 patients closely resembled those described for patients in the United States (presence of an inoculation eschar, maculopapular rash often associated with pustules or vesicles, infrequent gastrointestinal manifestations, and relatively benign clinical course). Many R. parkeri infections in South America are likely to be misdiagnosed as other infectious diseases, including Rocky Mountain spotted fever, dengue, or leptospirosis.

PDF

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381406/pdf/10-1857_finalS.pdf

December 7, 2012 at 2:56 pm

Older Posts


Calendar

October 2017
M T W T F S S
« Sep    
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Posts by Month

Posts by Category